Search Press releases Keywords From To 22 Oct 2021 Disposals of own shares Read More 20 Oct 2021 UCB to license its AI technology that improves identification of Osteoporosis to ImageBiopsy Lab Read More 18 Oct 2021 Disposals of own shares Read More 16 Oct 2021 Update on U.S. FDA Review of Biologics License Application (BLA) for bimekizumab Read More 8 Oct 2021 Disposals of own shares Read More 29 Sep 2021 New BIMZELX[®]▼ (bimekizumab) two-year data in moderate to severe plaque psoriasis presented at the 30th European Academy of Dermatology and Venereology (EADV) Congress Read More Pagination First page Previous page Previous … Page 42 Page 43 Page 44 Page 45 Current page 46 Page 47 Page 48 Page 49 Page 50 … Page 46 of 69 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
